Issue 1, 2019

Recent developments in compounds acting in the DNA minor groove

Abstract

The macromolecule that carries genetic information, DNA, is considered as an exceptional target for diseases depending on cellular division of malignant cells (i.e. cancer), microbes (i.e. bacteria) or parasites (i.e. protozoa). To aim for a comprehensive review to cover all aspects related to DNA targeting would be an impossible task and, hence, the objective of the present review is to present, from a medicinal chemistry point of view, recent developments of compounds targeting the minor groove of DNA. Accordingly, we discuss the medicinal chemistry aspects of heterocyclic small-molecules binding the DNA minor groove, as novel anticancer, antibacterial and antiparasitic agents.

Graphical abstract: Recent developments in compounds acting in the DNA minor groove

Article information

Article type
Review Article
Submitted
28 Aug 2018
Accepted
11 Dec 2018
First published
12 Dec 2018

Med. Chem. Commun., 2019,10, 26-40

Recent developments in compounds acting in the DNA minor groove

A. Rahman, P. O'Sullivan and I. Rozas, Med. Chem. Commun., 2019, 10, 26 DOI: 10.1039/C8MD00425K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements